vs
Side-by-side financial comparison of ACADIA PHARMACEUTICALS INC (ACAD) and COASTAL FINANCIAL CORP (CCB). Click either name above to swap in a different company.
ACADIA PHARMACEUTICALS INC is the larger business by last-quarter revenue ($268.1M vs $138.0M, roughly 1.9× COASTAL FINANCIAL CORP). On growth, ACADIA PHARMACEUTICALS INC posted the faster year-over-year revenue change (9.7% vs -5.8%). Over the past eight quarters, ACADIA PHARMACEUTICALS INC's revenue compounded faster (5.3% CAGR vs -3.6%).
Acadia Pharmaceuticals Inc. is a biopharmaceutical company headquartered in Del Mar, San Diego, California.
Fidelity National Financial, Inc., is an American provider of title insurance and settlement services to the real estate and mortgage industries. A Fortune 500 company, Fidelity National Financial generated approximately $8.469 billion in annual revenue in 2019 from its title and real estate-related operations. The company was the first instance of an attorney licensed by a Native American Tribe being certified as "authorized house counsel" in the state of Florida.
ACAD vs CCB — Head-to-Head
Income Statement — Q1 FY2026 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $268.1M | $138.0M |
| Net Profit | $3.6M | — |
| Gross Margin | — | — |
| Operating Margin | -1.7% | 12.4% |
| Net Margin | 1.4% | — |
| Revenue YoY | 9.7% | -5.8% |
| Net Profit YoY | — | — |
| EPS (diluted) | $0.02 | $0.84 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q1 26 | $268.1M | — | ||
| Q4 25 | $284.0M | $138.0M | ||
| Q3 25 | $278.6M | $144.7M | ||
| Q2 25 | $264.6M | $119.4M | ||
| Q1 25 | $244.3M | $139.5M | ||
| Q4 24 | $259.6M | $146.5M | ||
| Q3 24 | $250.4M | $151.1M | ||
| Q2 24 | $242.0M | $135.3M |
| Q1 26 | $3.6M | — | ||
| Q4 25 | $273.6M | — | ||
| Q3 25 | $71.8M | $13.6M | ||
| Q2 25 | $26.7M | $11.0M | ||
| Q1 25 | $19.0M | $9.7M | ||
| Q4 24 | $143.7M | — | ||
| Q3 24 | $32.8M | $13.5M | ||
| Q2 24 | $33.4M | $11.6M |
| Q1 26 | — | — | ||
| Q4 25 | 90.8% | — | ||
| Q3 25 | 92.2% | — | ||
| Q2 25 | 92.2% | — | ||
| Q1 25 | 91.7% | — | ||
| Q4 24 | 91.6% | — | ||
| Q3 24 | 92.5% | — | ||
| Q2 24 | 92.5% | — |
| Q1 26 | -1.7% | — | ||
| Q4 25 | 6.1% | 12.4% | ||
| Q3 25 | 12.8% | 12.4% | ||
| Q2 25 | 12.2% | 12.0% | ||
| Q1 25 | 7.9% | 8.4% | ||
| Q4 24 | 59.1% | 11.7% | ||
| Q3 24 | 12.6% | 10.8% | ||
| Q2 24 | 12.6% | 11.1% |
| Q1 26 | 1.4% | — | ||
| Q4 25 | 96.3% | — | ||
| Q3 25 | 25.8% | 9.4% | ||
| Q2 25 | 10.1% | 9.2% | ||
| Q1 25 | 7.8% | 7.0% | ||
| Q4 24 | 55.4% | — | ||
| Q3 24 | 13.1% | 8.9% | ||
| Q2 24 | 13.8% | 8.6% |
| Q1 26 | $0.02 | — | ||
| Q4 25 | $1.61 | $0.84 | ||
| Q3 25 | $0.42 | $0.88 | ||
| Q2 25 | $0.16 | $0.71 | ||
| Q1 25 | $0.11 | $0.63 | ||
| Q4 24 | $0.86 | $0.95 | ||
| Q3 24 | $0.20 | $0.97 | ||
| Q2 24 | $0.20 | $0.84 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | — | — |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | — | $491.0M |
| Total Assets | $1.6B | $4.7B |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | — | ||
| Q4 25 | $177.7M | — | ||
| Q3 25 | $258.0M | — | ||
| Q2 25 | $253.6M | — | ||
| Q1 25 | $217.7M | — | ||
| Q4 24 | $319.6M | — | ||
| Q3 24 | $155.1M | — | ||
| Q2 24 | $177.1M | — |
| Q1 26 | — | — | ||
| Q4 25 | $1.2B | $491.0M | ||
| Q3 25 | $917.3M | $475.3M | ||
| Q2 25 | $822.4M | $461.7M | ||
| Q1 25 | $765.2M | $449.9M | ||
| Q4 24 | $732.8M | $438.7M | ||
| Q3 24 | $577.2M | $331.9M | ||
| Q2 24 | $516.7M | $316.7M |
| Q1 26 | $1.6B | — | ||
| Q4 25 | $1.6B | $4.7B | ||
| Q3 25 | $1.3B | $4.6B | ||
| Q2 25 | $1.2B | $4.5B | ||
| Q1 25 | $1.1B | $4.3B | ||
| Q4 24 | $1.2B | $4.1B | ||
| Q3 24 | $976.9M | $4.1B | ||
| Q2 24 | $914.1M | $4.0B |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | — | $254.6M |
| Free Cash FlowOCF − Capex | — | $246.1M |
| FCF MarginFCF / Revenue | — | 178.3% |
| Capex IntensityCapex / Revenue | — | 6.1% |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | — | $436.4M |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | — | ||
| Q4 25 | $-48.7M | $254.6M | ||
| Q3 25 | $74.3M | $59.0M | ||
| Q2 25 | $64.0M | $66.0M | ||
| Q1 25 | $20.3M | $71.7M | ||
| Q4 24 | $40.4M | $259.8M | ||
| Q3 24 | $63.2M | $62.6M | ||
| Q2 24 | $25.0M | $72.1M |
| Q1 26 | — | — | ||
| Q4 25 | — | $246.1M | ||
| Q3 25 | $73.9M | $57.4M | ||
| Q2 25 | — | $64.0M | ||
| Q1 25 | — | $68.9M | ||
| Q4 24 | — | $249.9M | ||
| Q3 24 | $63.2M | $60.2M | ||
| Q2 24 | — | $69.5M |
| Q1 26 | — | — | ||
| Q4 25 | — | 178.3% | ||
| Q3 25 | 26.5% | 39.7% | ||
| Q2 25 | — | 53.6% | ||
| Q1 25 | — | 49.4% | ||
| Q4 24 | — | 170.6% | ||
| Q3 24 | 25.2% | 39.8% | ||
| Q2 24 | — | 51.3% |
| Q1 26 | — | — | ||
| Q4 25 | — | 6.1% | ||
| Q3 25 | 0.1% | 1.2% | ||
| Q2 25 | — | 1.7% | ||
| Q1 25 | — | 2.0% | ||
| Q4 24 | — | 6.8% | ||
| Q3 24 | 0.0% | 1.6% | ||
| Q2 24 | — | 1.9% |
| Q1 26 | — | — | ||
| Q4 25 | -0.18× | — | ||
| Q3 25 | 1.03× | 4.34× | ||
| Q2 25 | 2.40× | 5.99× | ||
| Q1 25 | 1.07× | 7.37× | ||
| Q4 24 | 0.28× | — | ||
| Q3 24 | 1.93× | 4.65× | ||
| Q2 24 | 0.75× | 6.22× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
ACAD
Segment breakdown not available.
CCB
| Other | $74.7M | 54% |
| Baa S Credit Enhancements | $47.3M | 34% |
| Baa S Program Income | $8.4M | 6% |
| Transaction Fees | $4.9M | 4% |
| Servicing And Other Baa S Fees | $1.6M | 1% |
| Baa S Fraud Enhancements | $1.1M | 1% |
